Work

Abstract 153: Improvement of monoclonal antibody therapy against cancer through engineering stem cell-derived CD16-enhanced universal NKT cells.

Year: 2026
Type: conference-abstract
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W7148719394
Cites:
Cited by: 1
Related to: